-
Real Time Chart
-
Stock Profile
-
Stock Fundamentals
Financials As Reported
-
accession Number
0000950170-23-017462
-
accounts Payable Current
6,483,000
-
accumulated Depreciation Depletion And Amortization Property Plant And Equipment
7,791,000
-
accumulated Other Comprehensive Income Loss Net Of Tax
--3,038,000
-
allocated Share Based Compensation Expense
9,385,000
-
amendment Flag
false
-
assets
613,905,000
-
assets Current
411,550,000
-
cash And Cash Equivalents At Carrying Value
50,152,000
-
cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
--18,225,000
-
cik
1,815,442
-
city Area Code
857
-
common Stock Par Or Stated Value Per Share
0.0001
-
common Stock Shares Authorized
150,000,000
-
common Stock Shares Issued
55,276,226
-
common Stock Shares Outstanding
55,276,226
-
comprehensive Income Net Of Tax
--39,017,000
-
contract With Customer Liability
57,114,000
-
contract With Customer Liability Current
32,248,000
-
current Fiscal Year End Date
--12-31
-
date Filed
2023-05-04
-
depreciation
900,000
-
depreciation Depletion And Amortization
879,000
-
document Fiscal Period Focus
Q1
-
document Fiscal Year Focus
2,023
-
document Period End Date
2023-03-31
-
document Transition Report
false
-
document Type
10-Q
-
earnings Per Share Basic
-0.7
-
earnings Per Share Diluted
-0.7
-
entity Address Address Line 1
200 Arsenal Yards Blvd
-
entity Address City Or Town
Watertown
-
entity Address Postal Zip Code
2,472
-
entity Address State Or Province
MA
-
entity Central Index Key
1,815,442
-
entity Current Reporting Status
Yes
-
entity Emerging Growth Company
false
-
entity File Number
001-39460
-
entity Filer Category
Large Accelerated Filer
-
entity Incorporation State Country Code
DE
-
entity Interactive Data Current
Yes
-
entity Name
Kymera Therapeutics, Inc.
-
entity Registrant Name
KYMERA THERAPEUTICS, INC.
-
entity Shell Company
false
-
entity Small Business
false
-
entity Tax Identification Number
81-2992166
-
finance Lease Liability
2,328,000
-
finance Lease Liability Current
1,339,000
-
finance Lease Liability Noncurrent
989,000
-
finance Lease Liability Payments Due
2,558,000
-
finance Lease Liability Payments Due Next Twelve Months
839,000
-
finance Lease Liability Payments Due Year Four
100,000
-
finance Lease Liability Payments Due Year Three
133,000
-
finance Lease Liability Payments Due Year Two
402,000
-
finance Lease Liability Undiscounted Excess Amount
230,000
-
income Tax Expense Benefit
0
-
increase Decrease In Accounts Payable
2,217,000
-
increase Decrease In Contract With Customer Liability
--6,145,000
-
interest Paid Net
52,000
-
irs Number
812,992,166
-
lessee Operating Lease Liability Payments Due
118,515,000
-
lessee Operating Lease Liability Payments Due Next Twelve Months
11,482,000
-
lessee Operating Lease Liability Payments Due Year Four
12,881,000
-
lessee Operating Lease Liability Payments Due Year Three
12,506,000
-
lessee Operating Lease Liability Payments Due Year Two
12,142,000
-
lessee Operating Lease Liability Undiscounted Excess Amount
52,086,000
-
liabilities
151,900,000
-
liabilities And Stockholders Equity
613,905,000
-
liabilities Current
61,933,000
-
local Phone Number
285-5300
-
net Cash Provided By Used In Financing Activities
1,159,000
-
net Cash Provided By Used In Investing Activities
24,584,000
-
net Cash Provided By Used In Operating Activities
--43,968,000
-
net Income Loss
--40,928,000
-
operating Expenses
54,792,000
-
operating Income Loss
--45,326,000
-
operating Lease Cost
2,521,000
-
operating Lease Liability
66,429,000
-
operating Lease Liability Current
2,554,000
-
operating Lease Liability Noncurrent
63,875,000
-
operating Lease Right Of Use Asset
56,604,000
-
other Assets Noncurrent
3,155,000
-
other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
1,911,000
-
other Liabilities Current
807,000
-
other Liabilities Noncurrent
237,000
-
other Nonoperating Income Expense
4,398,000
-
payments To Acquire Property Plant And Equipment
4,009,000
-
period End
1,680,220,800,000
-
period Start
1,672,531,200,000
-
property Plant And Equipment Gross
25,223,000
-
property Plant And Equipment Net
17,432,000
-
report Link
https://www.sec.gov/Archives/edgar/data/1815442/000095017023017462/kymr-20230331_htm.xml
-
research And Development Expense
42,227,000
-
retained Earnings Accumulated Deficit
--424,700,000
-
revenue From Contract With Customer Excluding Assessed Tax
9,466,000
-
share Based Compensation
9,385,000
-
stockholders Equity
462,005,000
-
trading Symbol
KYMR
-
update
1970-01-01
-
variable Lease Cost
220,000
-
weighted Average Number Of Diluted Shares Outstanding
58,187,038
-
weighted Average Number Of Shares Outstanding Basic
58,187,038
-
id
REPORTED_FINANCIALS
-
key
KYMR
-
subkey
10-Q
-
date
2023-05-04
-
updated
2023-05-05
-
Symbol Info
-
Symbol Over View
-
Technical Analysis
KYMR stock fundamentals - financials as reported